Boc-Asp-OtBuCAS# 34582-32-6 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 34582-32-6 | SDF | Download SDF |
| PubChem ID | 7010517 | Appearance | Powder |
| Formula | C13H23NO6 | M.Wt | 289.4 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in water or 1% acetic acid | ||
| Chemical Name | (3S)-4-[(2-methylpropan-2-yl)oxy]-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxobutanoic acid | ||
| SMILES | CC(C)(C)OC(=O)C(CC(=O)O)NC(=O)OC(C)(C)C | ||
| Standard InChIKey | RAUQRYTYJIYLTF-QMMMGPOBSA-N | ||
| Standard InChI | InChI=1S/C13H23NO6/c1-12(2,3)19-10(17)8(7-9(15)16)14-11(18)20-13(4,5)6/h8H,7H2,1-6H3,(H,14,18)(H,15,16)/t8-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Boc-Asp-OtBu Dilution Calculator
Boc-Asp-OtBu Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.4554 mL | 17.2771 mL | 34.5543 mL | 69.1085 mL | 86.3856 mL |
| 5 mM | 0.6911 mL | 3.4554 mL | 6.9109 mL | 13.8217 mL | 17.2771 mL |
| 10 mM | 0.3455 mL | 1.7277 mL | 3.4554 mL | 6.9109 mL | 8.6386 mL |
| 50 mM | 0.0691 mL | 0.3455 mL | 0.6911 mL | 1.3822 mL | 1.7277 mL |
| 100 mM | 0.0346 mL | 0.1728 mL | 0.3455 mL | 0.6911 mL | 0.8639 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Boc-Asp-OtBu
- Ketotifen Fumarate
Catalog No.:BCC4531
CAS No.:34580-14-8
- D-(+)-Mannose
Catalog No.:BCC8311
CAS No.:3458-28-4
- SF1670
Catalog No.:BCC5482
CAS No.:345630-40-2
- SNS-032 (BMS-387032)
Catalog No.:BCC1152
CAS No.:345627-80-7
- Loperamide HCl
Catalog No.:BCC4380
CAS No.:34552-83-5
- Madecassoside
Catalog No.:BCN1012
CAS No.:34540-22-2
- 6,7-Dehydroferruginol
Catalog No.:BCN3218
CAS No.:34539-84-9
- Beta,beta-Dimethylacrylalkannin
Catalog No.:BCN2767
CAS No.:34539-65-6
- Arnicolide D
Catalog No.:BCN7975
CAS No.:34532-68-8
- Arnicolide C
Catalog No.:BCN7978
CAS No.:34532-67-7
- 1,3,6-Trihydroxy-2,5-dimethoxyxanthone
Catalog No.:BCN7216
CAS No.:345287-92-5
- Myricanol triacetate
Catalog No.:BCN5281
CAS No.:34509-52-9
- SB 611812
Catalog No.:BCC6257
CAS No.:345892-71-9
- SUN-B 8155
Catalog No.:BCC7405
CAS No.:345893-91-6
- Amicarbalide
Catalog No.:BCC8117
CAS No.:3459-96-9
- MM 11253
Catalog No.:BCC7782
CAS No.:345952-44-5
- Wilfornine A
Catalog No.:BCN3099
CAS No.:345954-00-9
- AS601245
Catalog No.:BCC6464
CAS No.:345987-15-7
- 5-hydroxypyrazine-2-carboxylic acid
Catalog No.:BCC1311
CAS No.:34604-60-9
- Maltotetraose
Catalog No.:BCN6709
CAS No.:34612-38-9
- Maltopentaose
Catalog No.:BCN8421
CAS No.:34620-76-3
- Maltohexaose
Catalog No.:BCN6710
CAS No.:34620-77-4
- 2-Benzoyloxy-3-hydroxynortropane
Catalog No.:BCN1872
CAS No.:34622-25-8
- 1-Methoxycarbonyl-beta-carboline
Catalog No.:BCN5282
CAS No.:3464-66-2
Efficient Fmoc/solid-phase synthesis of Abu(P)-containing peptides using Fmoc-Abu(PO3Me2)-OH.[Pubmed:7822106]
Int J Pept Protein Res. 1994 Sep;44(3):288-94.
The synthesis of the two 4-phosphono-2-aminobutanoyl-containing peptides, Leu-Arg-Arg-Val-Abu(P)-Leu-Gly-OH.CF3CO2H and Ile-Val-Pro-Asn-Abu(P)-Val-Glu-Glu-OH.CF3CO2H was accomplished by the use of Fmoc-Abu(PO3Me2)-OH in Fmoc/solid-phase peptide synthesis. The protected phosphoamino acid, Fmoc-Abu(PO3Me2)-OH, was prepared from Boc-Asp-OtBu in seven steps, the formation of the C-P linkage being effected by the treatment of Boc-Asa-OtBu with dimethyl trimethylsilyl phosphite. Peptide synthesis was performed using Wang Resin as the polymer support with both peptides assembled by the use of PyBOP for the coupling of Fmoc amino acids and 20% piperidine for cleavage of the Fmoc group from the Fmoc-peptide after each coupling cycle. Cleavage of the peptide from the resin and peptide deprotection was accomplished by the treatment of the peptide-resin with 5% thioanisole/TFA followed by cleavage of the methyl phosphonate group by 1 M bromotrimethylsilane/1 M thioanisole in TFA.
Synthesis of the C-terminal half of thymosin alpha 1 by the polymeric reagent method.[Pubmed:6832888]
Int J Pept Protein Res. 1983 Feb;21(2):145-54.
In this report we further show the utility and efficiency of polymer-bound 1-hydroxybenzotriazole (PHBT) as an almost ideal support for the polymeric reagent method of peptide synthesis. This was demonstrated by the synthesis of thymosin alpha 1 (15-28), in which two suitably blocked segments, Boc-Asp (OtBu)-Leu-Lys (2Cz)-Glu (OBzl)-Lys (2Cz)-Lys (2Cz)-OH (3) and Boc-Glu (OBzl)-Val-Val-Glu (OBzl)-Glu (OBzl)-Ala-Glu (OBzl)-Asn-OBzl (2), were prepared entirely by utilizing PHBT activation for each coupling step. After appropriate deblocking of 2, segments 2 and 3 were coupled by the DCC-HOBT method, followed by complete deblocking and ion-exchange chromatographic purification, affording the C-terminal half of thymosin alpha 1, H-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH (1).
